PURPOSE: To investigate the potential of conductive interstitial thermal therapy (CITT) to inhibit recurrence and metastasis in a partially resected tumour model. METHOD: Fifteen New Zealand white rabbits were implanted with VX2 tumour intramuscularly in the rear thigh. Once the tumour size reached 20-25 mm in diameter, three animals were randomly selected to serve as controls, while the remaining animals were designated as the study group and treated with CITT. In the CITT group, the partially resected tumour and margins were thermally ablated. In the control group the tumour was partially resected to simulate positive margins. The animals were monitored for up to 12 weeks. At the endpoint, the animals were sacrificed, and whole-body diagnostic necropsy was conducted immediately. RESULTS: Recurrences and metastatic lesions were observed in iliac and popliteal lymph nodes and abdomens of all control animals. In contrast, the observed rate of recurrence and metastatic lesion was 0% among CITT-treated animals, significantly less than the >or=50% null-hypothesis rate expected upon treatment failure (exact binomial P = 0.0002). Complete histopathological healing was obtained in 2 of 12 rabbits, and residual inflammation remained at the ablation site up to 12 weeks post-ablation in 10 of 12 rabbits. This pattern of necrosis and inflammatory response was not observed in any of the control rabbits. CONCLUSIONS: The CITT device effectively ablated partially resected VX2 carcinoma in a rabbit model, and inhibited recurrence and metastasis in this model. CITT evoked an inflammatory response that may be linked to the mechanism involved in reduced metastatic spread.
PURPOSE: To investigate the potential of conductive interstitial thermal therapy (CITT) to inhibit recurrence and metastasis in a partially resected tumour model. METHOD: Fifteen New Zealand white rabbits were implanted with VX2 tumour intramuscularly in the rear thigh. Once the tumour size reached 20-25 mm in diameter, three animals were randomly selected to serve as controls, while the remaining animals were designated as the study group and treated with CITT. In the CITT group, the partially resected tumour and margins were thermally ablated. In the control group the tumour was partially resected to simulate positive margins. The animals were monitored for up to 12 weeks. At the endpoint, the animals were sacrificed, and whole-body diagnostic necropsy was conducted immediately. RESULTS: Recurrences and metastatic lesions were observed in iliac and popliteal lymph nodes and abdomens of all control animals. In contrast, the observed rate of recurrence and metastatic lesion was 0% among CITT-treated animals, significantly less than the >or=50% null-hypothesis rate expected upon treatment failure (exact binomial P = 0.0002). Complete histopathological healing was obtained in 2 of 12 rabbits, and residual inflammation remained at the ablation site up to 12 weeks post-ablation in 10 of 12 rabbits. This pattern of necrosis and inflammatory response was not observed in any of the control rabbits. CONCLUSIONS: The CITT device effectively ablated partially resected VX2 carcinoma in a rabbit model, and inhibited recurrence and metastasis in this model. CITT evoked an inflammatory response that may be linked to the mechanism involved in reduced metastatic spread.
Authors: Gal Shafirstein; Wolfgang Bäumler; Moshe Lapidoth; Scott Ferguson; Paula E North; Milton Waner Journal: Lasers Surg Med Date: 2004 Impact factor: 4.025
Authors: C Cellini; S T Hollenbeck; P Christos; D Martins; J Carson; S Kemper; E Lavigne; E Chan; R Simmons Journal: Ann Surg Oncol Date: 2004-09-20 Impact factor: 5.344
Authors: Philip S Mullenix; Daniel G Cuadrado; Scott R Steele; Matthew J Martin; Craig S See; Alan L Beitler; Preston L Carter Journal: Am J Surg Date: 2004-05 Impact factor: 2.565
Authors: Viola M M van Houten; C René Leemans; J Alain Kummer; Janny Dijkstra; Dirk J Kuik; Michiel W M van den Brekel; Gordon B Snow; Ruud H Brakenhoff Journal: Clin Cancer Res Date: 2004-06-01 Impact factor: 12.531
Authors: Jeong Min Lee; Sang Won Kim; Gyung Ho Chung; Sang Yong Lee; Young Min Han; Chong Soo Kim Journal: Eur Radiol Date: 2002-10-09 Impact factor: 5.315
Authors: Beata D Przybyla; Gal Shafirstein; Nathan A Koonce; Jessica S Webber; Robert J Griffin Journal: Int J Hyperthermia Date: 2012 Impact factor: 3.914
Authors: Beata D Przybyla; Gal Shafirstein; Sagar J Vishal; Richard A Dennis; Robert J Griffin Journal: Int J Oncol Date: 2013-11-21 Impact factor: 5.650
Authors: Gal Shafirstein; David A Bellnier; Emily Oakley; Sasheen Hamilton; Michael Habitzruther; Lawrence Tworek; Alan Hutson; Joseph A Spernyak; Sandra Sexton; Leslie Curtin; Steven G Turowski; Hassan Arshad; Barbara Henderson Journal: Br J Cancer Date: 2018-10-24 Impact factor: 7.640